AtriCure (NASDAQ:ATRC) is set to give its latest quarterly earnings report on Tuesday, 2026-02-17. Here's what investors need to know before the announcement.
Analysts estimate that AtriCure will report an earnings per share (EPS) of $-0.04.
The announcement from AtriCure is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Historical Earnings Performance
During the last quarter, the company reported an EPS beat by $0.10, leading to a 3.81% drop in the share price on the subsequent day.
Here's a look at AtriCure's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.11 | -0.16 | -0.22 | -0.15 |
| EPS Actual | -0.01 | -0.02 | -0.14 | -0.08 |
| Price Change % | -4.00 | 11.00 | -14.00 | -7.00 |
AtriCure Share Price Analysis
Shares of AtriCure were trading at $31.8 as of February 12. Over the last 52-week period, shares are down 14.57%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
Analyst Opinions on AtriCure
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on AtriCure.
With analyst ratings, AtriCure has a consensus rating of . The average one-year price target is $, indicating a potential .
To track all earnings releases for AtriCure visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
- No comments yet. Be the first to comment!